EMA Recommends Granting a Conditional Marketing Authorisation for Teclistamab
It is indicated as monotherapy in adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies
Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.
MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23
Make sure you check these pages frequently, or sign up to our newsletter! To sign up for ESMO newsletters, create a myESMO account here and select the newsletters you’d like to receive.
It is indicated as monotherapy in adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies
Findings from a pivotal single-arm phase II study
Findings from the CHRONOS study
Evidence for efficacy is based on the results from the ARASENS study
New anticancer drugs substantially reduce the risk of death and tumour progression, but only marginally extend patient survival
It is indicated for the first-line treatment of advanced melanoma in adults and adolescents 12 years of age and older with tumour cell PD-L1 expression < 1%
Findings from the single-arm, phase II study
Findings from the TUXEDO-1 study
Findings from the ARCAGEN study (EORTC-1843)
Findings from an analysis of data from two ovarian cancer consortia
Genetic testing, along with assessment of clinical risk factors, could be used to identify survivors at high risk for severe obesity and associated cardio-metabolic complications
This radiopharmaceutical precursor must be used only for the radiolabelling of carrier medicines that have been specifically developed and authorised for radiolabelling with lutetium chloride
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.